The Role of Gut Microbiota and Its Produced Metabolites in Obesity, Dyslipidemia, Adipocyte Dysfunction, and Its Interventions
Obesity is becoming an increasing problem worldwide and is often, but not invariably, associated with dyslipidemia. The gut microbiota is increasingly linked to cardiovascular disease, nonalcoholic fatty liver disease, and type 2 diabetes mellitus. However, relatively little focus has been attribute...
Main Authors: | Max S. Z. Zwartjes, Victor E. A. Gerdes, Max Nieuwdorp |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/11/8/531 |
Similar Items
-
Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
by: Pei-Yi Chen, et al.
Published: (2021-07-01) -
The beneficial effects of a water-based aerobic exercise session on the blood lipids of women with dyslipidemia are independent of their training status
by: Rochelle Rocha Costa, et al. -
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
by: Jacqueline Hoozemans, et al.
Published: (2021-05-01) -
ANALYSIS OF THE INTERACTION OF LIPID METABOLISM ALLELES IN DYSLIPIDEMIA
by: I. V. Nikolaev, et al.
Published: (2015-01-01) -
Ameliorative Effects of Anthocyanin Metabolites on Western Diet-Induced NAFLD by Modulating Co-Occurrence Networks of Gut Microbiome
by: Hironobu Nakano, et al.
Published: (2023-09-01)